Pulmonary Arterial Hypertension has gone from a disease that causes rapid death to a more chronic condition. Yet, improved survival is associated with major challenges for clinicians as most patients remain with poor quality of life and limited exercise capacity. The effects of exercise training on exercise capacity have been largely evaluated and showed an improvement in 6-minutes walking distance (6MWD), peak V'O2. It is also known that exercise program improves quality of life. Maximal volitional and nonvolitional strength of the quadriceps are reduced in patients with Pulmonary Arterial Hypertension and correlated to exercise capacity. Moreover, on the cellular level, alterations are observed in both the respiratory as well as the peripheral muscles. Muscle fiber size has been reported to be decreased in some studies or conversely unaltered in human and animal models. Reduction in type I fibers and a more anaerobic energy metabolism has also been reported, but not in all studies. Likewise, a loss in capillary density in quadriceps of patients with Pulmonary Arterial Hypertension and rats has been reported, but could not be confirmed in other studies. While the impact of exercise training on clinical outcomes such as exercise capacity or quality of life is well known, this data highlight the fact that the underlying causes of peripheral muscle weakness as well as the mechanisms underlying the clinical improvements observed with exercise programs are not completely understood. Improvement of muscle cell metabolism in part via the enhancement of oxidative cellular metabolism and decrease in intracellular lipid accumulation may play a role in improving muscle function and exercise capacity. In this study, we intend to evaluate the impact of a 12 weeks home-based rehabilitation program on peripheral muscle function and metabolism, focusing on lipid infiltration, oxidative metabolism and epigenetic factors that can be involved in metabolic syndrome, in patients with Pulmonary Arterial Hypertension.
The 12 weeks home-based rehabilitation program is detailed as follows: * 1st sessions at the hospital, in the presence of a physiotherapist/kinesiologist * 3 weeks of supervised home-based rehabilitation (using a telemonitoring system) 3 times a weeks * 9 weeks of unsupervised home-based rehabilitation (one phone call a week) Patients will be evaluated at baseline and at endpoint (12 weeks)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
1 supervised exercise session at the hospital; 3 weeks of supervised home-based exercise training (3x/week); 9 weeks of unsupervised home-based exercise training (3x/week)
University Institute of Cardiology and Respirology of Quebec
Québec, Canada
Epigenetic factors influencing muscle metabolism
Transcriptome analysis using RNA-seq
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Intramyocellular lipid accumulation
H-magnetic resonance spectroscopy and Oil red O technique
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Muscular mitochondrial phosphorylation (ATP synthesis)
phosphorus-31 Magnetic resonance spectroscopy saturation transfer
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Proportion of muscle fiber types
Ethanol modified technique
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
HbA1c
Serum HbA1c
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Insulin
Serum Insulin
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Glucose
Serum glucose
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Apolipoprotein A1
Serum Apolipoprotein A1
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Adiponectin
Serum Adiponectin
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Leptin
Serum leptin
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Volitional strength quadriceps
Maximal Voluntary force using isometric force meter
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Non-volitional strength of the quadriceps
Maximal non-Voluntary force using isometric force meter and magnetic stimulation of the femoral neve
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Maximal exercise capacity
Cardio-pulmonary exercise testing on a cycloergometer
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Functional Exercise capacity
6-MWD
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
Quality of life (QOL)
Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) questionnaire. The CAMPHOR questionnaire contains 65 items in total, 25 relating to symptoms, 15 relating to activities, and 25 relating to QoL. It is negatively weighted; a higher score indicates worse QoL and greater functional limitation. Symptom and QoL items are both scored out of 25: "yes/true" scores 1 and "no/not true" scores 0. Activity items have three possible responses (score 0-2), giving a score out of 30. Each CAMPHOR assessment takes an average of 10 min
Time frame: Changes between baseline and 12 weeks of exercise rehabilitation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.